| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGAGCUGAGAUCCUACAGGAGUCCAGGGCUGGAGAGAAAACCUCUGCGA… | 3062 nt | 0.5229 | |
| AGAGCUGAGAUCCUACAGGAGUCCAGGGCUGGAGAGAAAACCUCUGCGA… | 2795 nt | 0.5131 | |
| AGAGCUGAGAUCCUACAGGAGUCCAGGGCUGGAGAGAAAACCUCUGCGA… | 2924 nt | 0.5233 |
This gene encodes tissue-type plasminogen activator, a secreted serine protease that converts the proenzyme plasminogen to plasmin, a fibrinolytic enzyme. The encoded preproprotein is proteolytically processed by plasmin or trypsin to generate heavy and light chains. These chains associate via disulfide linkages to form the heterodimeric enzyme. This enzyme plays a role in cell migration and tissue remodeling. Increased enzymatic activity causes hyperfibrinolysis, which manifests as excessive bleeding, while decreased activity leads to hypofibrinolysis, which can result in thrombosis or embolism. Alternative splicing of this gene results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
A study in porcine skin demonstrated that bromine exposure significantly increased the PLAT transcript in the 45 s–7 d and 8 min–7 d post-exposure groups, identifying it as part of the coagulation system signaling pathway [Price et al. DOI:10.1016/j.toxlet.2008.08.007]. A study in mice demonstrated that the PLAT mRNA expression in bruises is time-dependent, peaking at 1 hour post-injury with a slight secondary increase at 72 hours, and its detection in specific cell types like neutrophils and macrophages provides a correlation with histologic wound healing stages useful for wound age estimation [Takamiya et al. DOI:10.1007/s00414-004-0453-4].